B. Metzler Seel. Sohn & Co. Holding Ag 10x Genomics, Inc. Call Options Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TXG
# of Institutions
291Shares Held
95.1MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA11MShares$172 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$169 Million2.31% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$100 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$99.9 Million1.67% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$99.9 Million0.1% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.49B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...